The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m 2 in Spain

Author: Fonseca Tiago  

Publisher: Informa Healthcare

ISSN: 1369-6998

Source: Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 926-938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content